Bryan W. Sherman - Concepedia

Author

Bryan W. Sherman

Research Triangle Park Foundation

Also Known As

Bryan Sherman, Bryan W Sherman, Bryan W. Sherman

Publications

469

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Aerie Pharmaceuticals (United States)

About

Bryan W. Sherman is an author at Research Triangle Park Foundation specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	267
2	Pharmacology	6	6	267
3	Natural Sciences	2	2	87
4	Biochemistry	2	2	41
5	Chemistry	1	1	62

Bryan W. Sherman

Publications

448

Citations

H-Index

Page 1

	Year	Citations
Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma Cheng‐Wen Lin, Bryan W. Sherman, Lori Moore, Journal of Ocular Pharmacology and Therapeutics	2017	181
Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma Jill M. Sturdivant, Susan M. Royalty, Cheng‐Wen Lin, Bioorganic & Medicinal Chemistry Letters Open-angle GlaucomaOphthalmologyMedicineGlaucomaTrabecular Meshwork	2016	104
Synthesis and Evaluation of Potent and Selective β<sub>3</sub> Adrenergic Receptor Agonists Containing Acylsulfonamide, Sulfonylsulfonamide, and Sulfonylurea Carboxylic Acid Isosteres David Uehling, Kelly H. Donaldson, David N. Deaton, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistrySelective BetaFunctional SelectivityMedicine	2001	62
Biarylaniline Phenethanolamines as Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonists David Uehling, Barry G. Shearer, Kelly H. Donaldson, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmacological StudyMedicinePhysiology	2006	41
2-(Anilinomethyl)imidazolines as α<sub>1</sub> Adrenergic Receptor Agonists: the Discovery of α<sub>1</sub><sub>a</sub> Subtype Selective 2‘-Alkylsulfonyl-Substituted Analogues Stephen J. Hodson, Michael J. Bishop, Jason D. Speake, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistrySulfide AnaloguesBiochemistrySulfone Oxidation State	2002	25
Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing heterobiaryl carboxylic acids Barry G. Shearer, Esther Y. Chao, David Uehling, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicineDrug DiscoveryReceptor (Biochemistry)Pharmacological Agent	2007	19
2-(Anilinomethyl)imidazolines as α1 adrenergic receptor agonists: α1a subtype selective 2′-heteroaryl compounds Jason D. Speake, Frank Navas, Michael J. Bishop, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineMechanism Of ActionReceptor (Biochemistry)	2003	16

Page 1